US6426072B1
(en)
|
2000-08-02 |
2002-07-30 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US6312695B1
(en)
|
1998-03-18 |
2001-11-06 |
Corixa Corporation |
Compounds and methods for therapy of lung cancer
|
US6660838B1
(en)
|
1998-03-18 |
2003-12-09 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
US6960570B2
(en)
|
1998-03-18 |
2005-11-01 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US6821518B1
(en)
|
1998-03-18 |
2004-11-23 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
US6706262B1
(en)
|
1998-03-18 |
2004-03-16 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
US6696247B2
(en)
|
1998-03-18 |
2004-02-24 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
US6531315B1
(en)
|
1998-03-18 |
2003-03-11 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US7258860B2
(en)
|
1998-03-18 |
2007-08-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US7049063B2
(en)
|
1998-03-18 |
2006-05-23 |
Corixa Corporation |
Methods for diagnosis of lung cancer
|
US6482597B1
(en)
|
1999-12-17 |
2002-11-19 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
US6518256B1
(en)
|
1998-03-18 |
2003-02-11 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
US6737514B1
(en)
|
1998-12-22 |
2004-05-18 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
DE69941627D1
(de)
*
|
1998-11-05 |
2009-12-17 |
Univ Michigan |
Für krebs
|
AU2004201392B2
(en)
*
|
1998-11-05 |
2007-06-14 |
The Regents Of The University Of Michigan |
S100 proteins and autoantibodies as serum markers for cancer
|
DE60039353D1
(de)
*
|
1999-04-02 |
2008-08-14 |
Corixa Corp |
Verbindungen und verfahren für therapie und diagnose von lungenkrebs
|
JP4287147B2
(ja)
|
2000-11-02 |
2009-07-01 |
イミュノセルラー・セラピューティクス・リミテッド |
小細胞肺癌(sclc)の検出および治療のためのモノクローナル抗体および細胞表面抗原
|
NZ528205A
(en)
*
|
2001-03-12 |
2006-09-29 |
Monogen Inc |
Cell-based detection and differentiation of disease status in a cytological sample using a panel comprising a plurality of probes
|
US7553488B2
(en)
*
|
2002-07-05 |
2009-06-30 |
UNIVERSITé LAVAL |
Antibodies against S100A8 and S100A9 proteins for modulating inflammatory reactions
|
AU2002951153A0
(en)
*
|
2002-09-02 |
2002-09-19 |
Proteome Systems Intellectual Property Pty Ltd |
An electrophoresis gel having improved swelling properties
|
TWI454275B
(zh)
*
|
2004-05-11 |
2014-10-01 |
Abgenomics Cooperatief Ua |
T細胞之死亡誘導表位
|
WO2006005186A1
(fr)
*
|
2004-07-13 |
2006-01-19 |
UNIVERSITé LAVAL |
Inhibiteurs de la proteine s100 utilises pour le traitement la leucemie
|
NZ580805A
(en)
|
2004-07-23 |
2011-02-25 |
Aspenbio Pharma Inc |
Methods and devices for diagnosis of appendicitis
|
US7659087B2
(en)
|
2004-07-23 |
2010-02-09 |
Aspenbio Pharma, Inc. |
Methods and devices for diagnosis of appendicitis
|
RS52243B
(en)
|
2005-05-18 |
2012-10-31 |
Astrazeneca Ab |
HETEROCYCLIC MELT INHIBITORS AND PROCEDURES FOR THEIR USE
|
KR100732298B1
(ko)
*
|
2005-11-24 |
2007-06-25 |
이화여자대학교 산학협력단 |
유비키틴 c-말단 가수분해제-l1을 이용한 암전이 진단용조성물
|
TW200813091A
(en)
|
2006-04-10 |
2008-03-16 |
Amgen Fremont Inc |
Targeted binding agents directed to uPAR and uses thereof
|
CL2007002225A1
(es)
|
2006-08-03 |
2008-04-18 |
Astrazeneca Ab |
Agente de union especifico para un receptor del factor de crecimiento derivado de plaquetas (pdgfr-alfa); molecula de acido nucleico que lo codifica; vector y celula huesped que la comprenden; conjugado que comprende al agente; y uso del agente de un
|
DK2057156T3
(en)
|
2006-08-23 |
2017-05-08 |
Kudos Pharm Ltd |
2-METHYLMORPHOLINPYRIDO, PYRAZO AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS
|
EP2138497A4
(fr)
|
2007-03-20 |
2012-01-04 |
Dainippon Sumitomo Pharma Co |
Nouveau composé d'adénine
|
TW200902018A
(en)
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Novel adenine compound
|
JP5592791B2
(ja)
*
|
2007-09-11 |
2014-09-17 |
キャンサー・プリヴェンション・アンド・キュア,リミテッド |
ヒト肺組織の病態を示すヒト血清中のタンパク質の同定
|
ES2522365T3
(es)
|
2007-10-11 |
2014-11-14 |
Astrazeneca Ab |
Derivados de pirrolo [2,3-D] pirimidina como inhibidores de proteína quinasas B
|
PL2222675T3
(pl)
|
2007-12-19 |
2014-02-28 |
Genentech Inc |
5-anilinoimidazopirydyny i sposoby zastosowania
|
US8486963B2
(en)
|
2007-12-21 |
2013-07-16 |
Genentech, Inc. |
Azaindolizines and methods of use
|
CN102264763B
(zh)
|
2008-09-19 |
2016-04-27 |
米迪缪尼有限公司 |
定向于dll4的抗体及其用途
|
UY32351A
(es)
|
2008-12-22 |
2010-07-30 |
Astrazeneca Ab |
Compuestos de pirimidinil indol para uso como inhibidores de atr
|
US20120114667A1
(en)
|
2008-12-23 |
2012-05-10 |
Medimmune Limited |
TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF
|
US8426402B2
(en)
|
2009-02-05 |
2013-04-23 |
Immunogen, Inc. |
Benzodiazepine derivatives
|
ES2703714T3
(es)
|
2009-03-12 |
2019-03-12 |
Cancer Prevention & Cure Ltd |
Métodos de identificación, evaluación, prevención y terapia de enfermedades pulmonares y kits de los mismos, incluida la identificación, evaluación, prevención y terapia de enfermedades en base al género
|
WO2010103094A1
(fr)
|
2009-03-13 |
2010-09-16 |
Cellzome Limited |
Dérivés de pyrimidine comme inhibiteurs du mtor
|
CA2758614A1
(fr)
|
2009-04-14 |
2010-10-21 |
Cellzome Limited |
Composes de pyrimidine substitues par fluoro en tant qu'inhibiteurs de jak3
|
US8389580B2
(en)
|
2009-06-02 |
2013-03-05 |
Duke University |
Arylcyclopropylamines and methods of use
|
EP2475648A1
(fr)
|
2009-09-11 |
2012-07-18 |
Cellzome Limited |
Composés de pyrimidine ortho-substitués en tant qu'inhibiteurs de jak
|
CN102666545B
(zh)
|
2009-10-20 |
2016-04-06 |
塞尔卓姆有限公司 |
作为jak抑制剂的杂环吡唑并嘧啶类似物
|
NO2504364T3
(fr)
|
2009-11-24 |
2018-01-06 |
|
|
JP2013512859A
(ja)
|
2009-12-03 |
2013-04-18 |
大日本住友製薬株式会社 |
トール様受容体(tlr)を介して作用するイミダゾキノリン
|
EP2521920A4
(fr)
*
|
2010-01-08 |
2013-06-05 |
Univ California |
Marqueurs de protéine pour détection du cancer du poumon et leurs procédés d'utilisation
|
MX341687B
(es)
|
2010-02-10 |
2016-08-30 |
Immunogen Inc |
"anticuerpos cd20 y su utilización".
|
WO2011107585A1
(fr)
|
2010-03-04 |
2011-09-09 |
Cellzome Limited |
Dérivés d'urée substituée par un morpholino en tant qu'inhibiteurs de mtor
|
CA2797772A1
(fr)
|
2010-04-30 |
2011-11-03 |
Cellzome Limited |
Composes de pyrazole comme inhibiteurs de jak
|
SA111320519B1
(ar)
|
2010-06-11 |
2014-07-02 |
Astrazeneca Ab |
مركبات بيريميدينيل للاستخدام كمثبطات atr
|
WO2012000970A1
(fr)
|
2010-07-01 |
2012-01-05 |
Cellzome Limited |
Triazolopyridines en tant qu'inhibiteurs de tyk2
|
WO2012022681A2
(fr)
|
2010-08-20 |
2012-02-23 |
Cellzome Limited |
Analogues de la hétérocyclyl pyrazolopyrimidine comme inhibiteurs sélectifs de la jak
|
CN103298794A
(zh)
|
2010-11-09 |
2013-09-11 |
塞尔卓姆有限公司 |
作为tyk2抑制剂的吡啶化合物及其氮杂类似物
|
MX343337B
(es)
|
2011-02-15 |
2016-11-01 |
Immunogen Inc |
Metodos de preparacion de conjugados.
|
EP2675793B1
(fr)
|
2011-02-17 |
2018-08-08 |
Cancer Therapeutics Crc Pty Limited |
Inhibiteurs de fak
|
EP2675794B1
(fr)
|
2011-02-17 |
2019-02-13 |
Cancer Therapeutics Crc Pty Limited |
Inhibiteurs sélectifs de fak
|
EP2694511A1
(fr)
|
2011-04-04 |
2014-02-12 |
Cellzome Limited |
Dérivés de dihydropyrrolopyrimidine en tant qu'inhibiteurs de la mtor
|
WO2012143320A1
(fr)
|
2011-04-18 |
2012-10-26 |
Cellzome Limited |
Composés (7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine comme inhibiteurs de la jak3
|
CA2843195A1
(fr)
|
2011-07-28 |
2013-01-31 |
Cellzome Limited |
Analogues d'heterocyclyl-pyrimidine en tant qu'inhibiteurs de jak
|
WO2013017480A1
(fr)
|
2011-07-29 |
2013-02-07 |
Cellzome Limited |
Dérivés de pyrazolo[4,3-c]pyridine en tant qu'inhibiteurs de jak
|
WO2013017479A1
(fr)
|
2011-07-29 |
2013-02-07 |
Cellzome Limited |
Dérivés de pyrazolo[4,3-c]pyridine en tant qu'inhibiteurs de jak
|
CN103874699A
(zh)
|
2011-09-20 |
2014-06-18 |
赛尔佐姆有限公司 |
吡唑并[4,3-c]吡啶衍生物作为激酶抑制剂
|
CA2849189A1
(fr)
|
2011-09-21 |
2013-03-28 |
Cellzome Limited |
Uree substituee par un groupe morpholino ou derives carbamate comme inhibiteurs de mtor
|
JP5995977B2
(ja)
|
2011-10-07 |
2016-09-21 |
セルゾーム リミテッド |
Mtor阻害剤としてのモルホリノ置換二環式ピリミジン尿素またはカルバメート誘導体
|
US20130178520A1
(en)
|
2011-12-23 |
2013-07-11 |
Duke University |
Methods of treatment using arylcyclopropylamine compounds
|
CN104169272A
(zh)
|
2011-12-23 |
2014-11-26 |
赛尔佐姆有限公司 |
作为激酶抑制剂的嘧啶-2,4-二胺衍生物
|
SI2859017T1
(sl)
|
2012-06-08 |
2019-05-31 |
Sutro Biopharma, Inc. |
Protitelesa, ki vsebujejo specifične nenaravne aminokislinske ostanke, postopki njihove priprave in postopki njihove uporabe
|
US9732161B2
(en)
|
2012-06-26 |
2017-08-15 |
Sutro Biopharma, Inc. |
Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
|
CN104736533B
(zh)
|
2012-08-17 |
2016-12-07 |
癌症治疗合作研究中心有限公司 |
Vegfr3抑制剂
|
EP2887965A1
(fr)
|
2012-08-22 |
2015-07-01 |
ImmunoGen, Inc. |
Dérivés de benzodiazépine cytotoxique
|
ES2907763T3
(es)
|
2012-08-31 |
2022-04-26 |
Sutro Biopharma Inc |
Aminoácidos modificados que comprenden un grupo azido
|
WO2014041349A1
(fr)
|
2012-09-12 |
2014-03-20 |
Cancer Therapeutics Crc Pty Ltd |
Pyrimidines ou pyridazines tétrahydropyran-4-yléthylamino- ou tétrahydropyranyl-4-éthyloxy utiles comme inhibiteurs de l'isoprényl-cystéine-carboxy-méthyl-transférase
|
WO2014045101A1
(fr)
|
2012-09-21 |
2014-03-27 |
Cellzome Gmbh |
Dérivés de tétrazolo quinoxaline utilisés comme inhibiteurs de la tankyrase
|
WO2014134486A2
(fr)
|
2013-02-28 |
2014-09-04 |
Immunogen, Inc. |
Conjugués comprenant des agents de liaison cellulaire (cba) et des agents cytotoxiques
|
JP6494533B2
(ja)
|
2013-02-28 |
2019-04-03 |
イミュノジェン・インコーポレーテッド |
細胞結合剤及び細胞毒性剤としてのマイタンシノイドを含む複合体
|
AR095443A1
(es)
|
2013-03-15 |
2015-10-14 |
Fundación Centro Nac De Investig Oncológicas Carlos Iii |
Heterociclos condensados con acción sobre atr
|
WO2014194030A2
(fr)
|
2013-05-31 |
2014-12-04 |
Immunogen, Inc. |
Conjugués comprenant des agents de liaison cellulaire et des agents cytotoxiques
|
US9764039B2
(en)
|
2013-07-10 |
2017-09-19 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
EP3055298B1
(fr)
|
2013-10-11 |
2020-04-29 |
Sutro Biopharma, Inc. |
Acides aminés modifiés comprenant des groupes fonctionnels de tétrazine, procédés de préparation et procédés d'utilisation associés
|
GB201510019D0
(en)
|
2015-06-09 |
2015-07-22 |
Cancer Therapeutics Crc Pty Ltd |
Compounds
|
EP3407917A1
(fr)
|
2016-01-27 |
2018-12-05 |
Sutro Biopharma, Inc. |
Conjugués d'anticorps anti-cd74, compositions comprenant des conjugués d'anticorps anti-cd74 et méthodes d'utilisations desdits conjugués d'anticorps anti-cd74
|
CN107459519A
(zh)
|
2016-06-06 |
2017-12-12 |
上海艾力斯医药科技有限公司 |
稠合嘧啶哌啶环衍生物及其制备方法和应用
|
CA3035081A1
(fr)
|
2016-09-02 |
2018-03-08 |
Dana-Farber Cancer Institute, Inc. |
Composition et methodes de traitement des dereglements des lymphocytes b
|
US10786502B2
(en)
|
2016-12-05 |
2020-09-29 |
Apros Therapeutics, Inc. |
Substituted pyrimidines containing acidic groups as TLR7 modulators
|
JP7071392B2
(ja)
|
2016-12-05 |
2022-05-18 |
アプロス セラピューティクス, インコーポレイテッド |
酸性基を含有するピリミジン化合物
|
CA3058481A1
(fr)
|
2017-04-04 |
2018-10-11 |
Lung Cancer Proteomics, Llc |
Profilage de proteine a base de plasma pour le pronostic precoce du cancer du poumon
|
WO2019023316A1
(fr)
|
2017-07-26 |
2019-01-31 |
Sutro Biopharma, Inc. |
Méthodes d'utilisation d'anticorps anti-cd74 et de conjugués d'anticorps dans le traitement d'un lymphome à cellules t
|
AU2018333945A1
(en)
|
2017-09-18 |
2020-03-26 |
Sutro Biopharma, Inc. |
Anti- folate receptor alpha antibody conjugates and their uses
|
NL2019801B1
(en)
|
2017-10-25 |
2019-05-02 |
Univ Leiden |
Delivery vectors
|
JP7351859B2
(ja)
|
2018-06-04 |
2023-09-27 |
アプロス セラピューティクス, インコーポレイテッド |
Tlr7の調節に関係する疾患を処置するのに有用な酸性基を含むピリミジン化合物
|
GB201810092D0
(en)
|
2018-06-20 |
2018-08-08 |
Ctxt Pty Ltd |
Compounds
|
GB201810581D0
(en)
|
2018-06-28 |
2018-08-15 |
Ctxt Pty Ltd |
Compounds
|
US20220047716A1
(en)
|
2018-09-17 |
2022-02-17 |
Sutro Biopharma, Inc. |
Combination therapies with anti-folate receptor antibody conjugates
|
EP3962951A1
(fr)
|
2019-05-03 |
2022-03-09 |
Sutro Biopharma, Inc. |
Conjugués d'anticorps anti-bcma
|
US20220298143A1
(en)
|
2019-08-31 |
2022-09-22 |
Etern Biopharma (Shanghai) Co., Ltd. |
Pyrazole Derivatives for FGFR Inhibitor and Preparation Method Thereof
|
WO2021178597A1
(fr)
|
2020-03-03 |
2021-09-10 |
Sutro Biopharma, Inc. |
Anticorps comprenant des étiquettes de glutamine spécifiques à un site, leurs procédés de préparation et d'utilisation
|
US20240058465A1
(en)
|
2022-06-30 |
2024-02-22 |
Sutro Biopharma, Inc. |
Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugates
|